Showing 311-320 of 4005 results for "".
The Doctor Will See All of You Now: New Approaches to Treating Parkinson's Disease
https://reachmd.com/programs/neurofrontiers/the-doctor-will-see-all-of-you-now-new-approaches-to-treating-parkinsons-disease/6535/Would it be better for Parkinson's patients to meet with their doctor in a group setting? Group visits are among the the novel approaches being studied for Parkinson's patients. Dr. Lisa Shulman, professor of neurology and co-director of the Maryland Parkinson's Disease and Movement Disorders CenterAdvances in Axial Spondyloarthritis: How the Treatment Landscape Is Evolving
https://reachmd.com/programs/living-rheum/advances-in-axial-spondyloarthritis-how-the-treatment-landscape-is-evolving/13950/Are you up to date on the latest therapeutic developments in axial spondyloarthritis? Find out what’s new with this essential recap.Beyond the Data: Emerging Tickborne Diseases
https://reachmd.com/programs/grand-rounds-nation/beyond-data-emerging-tickborne-diseases/9450/Dr. Phoebe Thorpe and Dr. Bobbi Pritt focus on the latest advances in diagnosing tickborne diseases.Writing the Red Book
https://reachmd.com/programs/clinicians-roundtable/writing-the-red-book/1757/What was it like to be the chair of the Red Book, the ultimate pediatric source on SARS, West Nile, MRSA, Rotovirus, Pandemic Flu. Host Dr. Bill Rutenberg talks with Dr. Jon Abrmason who previously chaired the Red Book committee for the American Academy of Pediatrics.Moving Medication to Market More Quickly
https://reachmd.com/programs/clinicians-roundtable/moving-medication-to-market-more-quickly/1981/Many are eagerly awaiting approval of certain drugs whether it be to cure a patient or to realize the research put into the development of the drug. Would a speedier drug approval process ultimately help or hinder our healthcare system? Join Dr. Larry Kaskel interviewing Peter Pitts, co-founder of tSugary Drinks and the Increasing Epidemic of Type-2 Diabetes
https://reachmd.com/programs/clinicians-roundtable/sugary-drinks-and-the-increasing-epidemic-of-type-2-diabetes/6642/Host Dr. Farhad Zangeneh welcomes Dr. Anthony J. Cannon as they discuss the recently published studies that reviewed the association of sugary drinks, childhood obesity and epidemic increase of Type-2 diabetes. What are we doing? Are we getting better? And, ultimately, what we can be doing today, asStopping aspirin after 1 month DAPT in ACS patients after stenting
https://reachmd.com/programs/acc-action-center/stopping-aspirin-after-1-month-dapt-in-acs-patients-after-stenting/24290/ACC.24 - Study results from the ULTIMATE-DAPT show that aspirin can be stopped in ACS patients who underwent PCI and tolerated 1 month of DAPT -ticagrelor and aspirin- well. "You will be doing a favor for your patients," said Gregg Stone.The Difficult Patient Demystified
https://reachmd.com/programs/clinicians-roundtable/the-difficult-patient-demystified/4589/Over the years, many studies have examined the ‘difficult' patient encounter. Consistently, these studies indicate that physicians deem nearly 1 in 6 outpatient appointments to be an arduous visit. These challenging episodes are often time-consuming and may also lead to adverse outcomes. Though it iCutaneous Toxicities in Graft-versus-host Disease
https://reachmd.com/conferences/masterclasses-in-dermatology-2025/cutaneous-toxicities-in-graft-versus-host-disease/33013/Meghan Heberton, MD, an assistant professor of dermatology at UT Southwestern Medical Center, talks about her presentation at Masterclasses in Dermatology on the latest updates on cutaneous toxicities in Graft-versus-host (GvHD) disease.Current Treatments for Peyronie's Disease
https://reachmd.com/programs/clinicians-roundtable/current-treatments-for-peyronies-disease/2624/What is known about the cause of Peyronie's Disease, and what are the latest treatments? Join host Dr. Larry Kaskel to discuss Peyronie's Disease with our guest, Dr. Paul Shin.